companydata.dkcompanydata.dk

NORDICCELL ApS: Financial statements 2021

CVR: 27293972

Source: annual report 2021, Danish Business Authority

01/07/2020 – 30/06/2021

NORDICCELL ApS (CVR 27293972) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 10,833,729 and a net result of DKK 3,743,723 compared with DKK 2,947,229 the year before. That is an increase of 26% compared with the year before. Equity in the 2021 report amounted to DKK 7,302,381. The solvency ratio was 50.3%. The company had 9 employees in the financial year.

Gross Profit
DKK 10,833,729
Profit/Loss
DKK 3,743,723
Equity
DKK 7,302,381
Total Assets
DKK 14,512,386
Employees
9

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2021-10.8 mio.3.7 mio.7.3 mio.9
2020-8.6 mio.2.9 mio.4.3 mio.9
2019-6.8 mio.886 t.2.3 mio.10
2018-6.5 mio.1.5 mio.2.9 mio.10
2017-7.1 mio.2.6 mio.4 mio.9

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like NORDICCELL ApS

Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.

Try the lead list generator

About NORDICCELL ApS

NORDICCELL ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2003. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Anders Bek-Pedersen. The company is owned by BEK-PEDERSEN HOLDING ApS. The company has 11 employees (2026). In 2025, the company reported a gross profit of DKK 8,909,296 and a net result of DKK 1,701,475 compared with DKK 1,272,903 the year before. Equity in the 2025 report amounted to DKK 4,976,358.

Source: annual report 2025, Danish Business Authority